QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.60
+1.82% today
Updated 2026-04-30
Market cap
$83.68M
P/E ratio
2.36
P/S ratio
1.56x
EPS (TTM)
$2.42
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Q32 Bio Inc (QTTB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $5.32M | $1.67M | $2.70M | $33.97M | $6.65M | $-6.65M | $0.00 | $53.74M |
| Revenue growth (YoY) | — | — | — | -68.7% | +62.2% | +1157.3% | -80.4% | -200.0% | +100.0% | — |
| Cost of revenue | $239797.00 | $684214.00 | — | — | — | $9.54M | $2.60M | $578000.00 | $487000.00 | $391000.00 |
| Gross profit | $-239797.00 | $-684214.00 | $5.32M | $1.67M | $2.70M | $24.43M | $6.65M | $-6.65M | $-487000.00 | $53.35M |
| Gross margin | — | — | 100.0% | 100.0% | 100.0% | 71.9% | 100.0% | 100.0% | — | 99.3% |
| R&D | $5.69M | $21.38M | $47.95M | $89.40M | $100.39M | $93.08M | $35.81M | $31.73M | $48.14M | $19.16M |
| SG&A | — | — | — | — | — | $6.76M | $10.06M | $9.88M | $17.96M | $17.68M |
| Operating income | $-10.00M | $-29.66M | $-59.93M | $-109.94M | $-130.26M | $-95.95M | $-39.23M | $-48.26M | $-66.10M | $16.90M |
| Operating margin | — | — | -1126.0% | -6599.2% | -4821.0% | -282.4% | -589.8% | 725.5% | — | 31.5% |
| EBITDA | $-7.81M | $-29.31M | $-58.64M | $-97.60M | $-119.79M | $-86.22M | $-38.85M | $-47.76M | $-45.30M | $17.29M |
| EBITDA margin | — | — | -1101.8% | -5858.2% | -4433.4% | -253.8% | -584.2% | 718.0% | — | 32.2% |
| EBIT | $-8.05M | $-29.99M | $-59.93M | $-103.92M | $-128.69M | $-95.76M | $-39.23M | $-48.26M | $-45.79M | $16.90M |
| Interest expense | — | — | — | — | — | — | — | — | $300000.00 | $1.10M |
| Income tax | $2.00 | $-4.00 | — | — | $-1.00 | $547000.00 | $62000.00 | $318000.00 | $21000.00 | — |
| Effective tax rate | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -0.6% | -0.1% | -0.6% | -0.0% | 0.0% |
| Net income | $-8.05M | $-29.99M | $-55.58M | $-103.92M | $-128.69M | $-95.76M | $-42.81M | $-53.74M | $-47.73M | $29.82M |
| Net income growth (YoY) | — | -272.7% | -85.3% | -87.0% | -23.8% | +25.6% | +55.3% | -25.5% | +11.2% | +162.5% |
| Profit margin | — | — | -1044.3% | -6237.5% | -4762.9% | -281.9% | -643.6% | 808.0% | — | 55.5% |